What adverse reactions happened during this study?
The most common adverse reaction was headache.
The table below shows the adverse reactions that happened in 3 or more of
the participants during the study. There were other adverse reactions, but these
happened in fewer participants.
Most common adverse reactions
Benralizumab Placebo
Adverse reaction (out of 427 participants) (out of 229 participants)
Headache 4.0% (17) 1.7% (4)
Fever 4.0% (17) 0.9% (2)
General weakness 1.6% (7) 1.3% (3)
Fatigue 1.6% (7) 1.3% (3)
Nausea 1.4% (6) 1.3% (3)
Chills 0.7% (3) 0.4% (1)
Dizziness 0.7% (3) 0.4% (1)
Diarrhea 0.5% (2) 0.4% (1)
Muscle pain 0.5% (2) 0.4% (1)
Vomiting 0.2% (1) 0.9% (2)
How has this study helped patients and
researchers?
This study helped researchers learn more about benralizumab for people with
severe asthma.
Researchers look at the results of many studies to decide which treatments work
best and are safest. This summary shows only the main results from this one study.
Other studies may provide new information or different results.
Further studies with benralizumab may be planned.
11 | Clinical Study Results